Valuation : Microba Life Sciences Limited

Market Cap 40.16M 28.8M 24.77M 23.37M 21.29M 39.8M 2.75B 278M 107M 1.4B 108M 106M 4.44B P/E 2027 *
-6.22x
P/E 2028 * -28x
Enterprise Value 32.74M 23.48M 20.19M 19.05M 17.36M 32.44M 2.24B 227M 87.33M 1.14B 88.17M 86.24M 3.62B EV / Sales 2027 *
1.66x
EV / Sales 2028 * 1.05x
Free-Float
63.14%
Yield 2027 *
-
Yield 2028 * -
1 day-1.75%
1 week+1.82%
Current month+3.70%
1 month+16.67%
3 months-11.11%
6 months-30.00%
Current year-26.32%
1 week 0.06
Extreme 0.055
0.06
1 month 0.05
Extreme 0.048
0.06
Current year 0.04
Extreme 0.036
0.1
1 year 0.04
Extreme 0.036
0.1
3 years 0.04
Extreme 0.036
0.38
5 years 0.04
Extreme 0.036
0.45
10 years 0.04
Extreme 0.036
0.45
Manager TitleAgeSince
Chief Executive Officer - 01/07/2021
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 01/01/2024
Director TitleAgeSince
Director/Board Member - 31/01/2017
Director/Board Member - -
Chairman - -
Date Insider Type Main position Quantity % Market Cap. Importance
11/19/24 A Buy

Chairman

100,000 0.0223%
11/19/24 A Buy

Chairman

100,000 0.0223%
11/19/24 A Buy

Director

200,000 0.0447%
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%+1.82%-33.33%-84.00% 28.8M
-1.26%-0.47%+92.08%+501.73% 47.01B
-4.40%-7.40%+12.46%+50.98% 24.89B
-1.91%-2.76%-15.37%-38.61% 6.86B
+4.81%-0.46%+4.15%+146.45% 5.85B
-0.40%+1.68%+16.26%+71.90% 3.35B
-2.91%-3.92%-31.85%+1,713.39% 2.5B
-0.28%+0.86%+135.43%+29.58% 2.26B
+3.00%+4.28%+33.33%+47.09% 2.24B
-2.03%-1.81%-18.64%-56.41% 1.78B
Average -0.71%-0.28%+19.45%+238.21% 9.68B
Weighted average by Cap. -1.65%-1.07%+50.42%+310.51%

Financials

2027 *2028 *
Net sales 19.67M 14.11M 12.13M 11.45M 10.43M 19.49M 1.35B 136M 52.47M 684M 52.97M 51.81M 2.17B 31.1M 22.31M 19.18M 18.1M 16.49M 30.82M 2.13B 216M 82.96M 1.08B 83.76M 81.93M 3.44B
Net income -6.8M -4.88M -4.19M -3.96M -3.6M -6.74M -466M -47.13M -18.14M -236M -18.31M -17.91M -751M -1.8M -1.29M -1.11M -1.05M -954K -1.78M -123M -12.47M -4.8M -62.6M -4.85M -4.74M -199M
Net Debt -7.42M -5.32M -4.58M -4.32M -3.93M -7.35M -509M -51.42M -19.79M -258M -19.98M -19.54M -820M -7.56M -5.42M -4.66M -4.4M -4.01M -7.49M -518M -52.4M -20.17M -263M -20.36M -19.91M -835M
Logo Microba Life Sciences Limited
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel.
Employees
-
Date Price Change Volume
09/09/26 A$0.0560 -1.75% 240
08/09/26 A$0.0570 +2.70% 30,231
07/09/26 A$0.0555 +0.91% 1,568
02/09/26 A$0.0550 -1.79% 122,393
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0560AUD
Average target price
0.1182AUD
Spread / Average Target
+111.11%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!